chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Per patient, eyes got really red, temp to 101.47.  Patient then had headache, and eyes started mattering.  MD told her to take Benadryl.
patient was administered vaccine 08/23/20 , patient noticed soreness to the injection site, 1 week later patient noticed a hard bump on the site, red, discomfort from shot. symptoms have not gone away
The pt became hoarse 45 minutes post vax and remained hoarse 24 hours later.
Covid symptoms started on 01/13/2022 with mild upper respiratory symptoms, a little bit of a runny nose, post nasal drop, and that's about it. On the evening of 01/15/2022 I started having terrible gastrointestinal symptoms like painful gas, frequent diarrhea at least 2 times an hour. I had that all throughout Saturday night and into Sunday morning. I also had several episodes of vomiting. It was miserable. I ended up going to the ER on Sunday 01/16/2022 and they gave me an injection of Zofran and about a half a bag of fluids. It was a horrible patient care experience and I ended up leaving. I went home and basically rode it out and pretty much threw up everything. The next couple of days I was basically just sipping water and Gatorade and didn't have anything to eat. I did have applesauce on Tuesday morning but that's it. That persisted but I felt better and started eating normally on the 21st and then I was back to work on the 24th. I did have some lingering fatigue for the first 3 days back to work, but by 01/27/2022 I was close to 100% by then.
The arm after the ZOSTAVAX. Swelling (about the size of a small cutie) redness, tenderness but not painful. Not hard to the touch. No red streaks going down the arm.
Information has been received from a registered school nurse concerning an approximately 11 year old female who, on an unspecified date during her sixth grade physical, was vaccinated with Gardasil. Subsequently the patient developed a "red, hot to touch area about the size of a baseball". The patient was taken out of school and taken to her physician. The patient's mother reported that the area was "bigger than it had been the night before". At the time of this report, the outcome of the event was unknown. NO further information is expected. This is one of two reports from the same source.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable Other HCP (patient).  A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at single dose for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient was supposed to go back on 13Jan2021 for second dose, but the week before, in Jan2021, she tested positive COVID-19. She had an appointment for the 15Jan2021. The patient wanted to know how many days she has to wait to get second dose.  Information on Lot/ Batch number requested.; Sender's Comments: The PFIZER-BIONTECH COVID-19 VACCINE provides protection after three weeks from the second dose.
10 min following vax (IM), pt devel fever 102.4, tachycardia,dizziness, chills & hot flashes. Tx w/Benadryl & Tylenol & recovered within 4 hr. Next day pt devel a "diffuse psoriatic dermatological rxn". See comments.
Patient had mild swelling, itching, redness, warm to the touch on the day after immunization.  She noted that the symptoms resolved on their own in about 48 hours.
Localized swelling, induration at the injection site of the right deltoid.  5 cm x 5 cm. Seen for CHDP physical examination 06/09/2011 (today). There is no increased swelling or induration over the past two days.
H1N1 injectable given 5 PM. Woke at 5 AM with hives, itching and later developed dyspnea. Relieved with PROVENTIL HFA. BENADRYL cleared hives-11 AM hives and dyspnea returned. Seen in my office.
This case was reported by a healthcare professional and described the occurrence of flu shot reaction in approximately 10 adult subjects of unspecified gender who were vaccinated with FLULAVAL (GlaxoSmithKline). On unspecified dates since September 2012, the subjects received unspecified dose of FLULAVAL (.5 ml, unknown, unknown arm). At an unspecified time after vaccination with FLULAVAL, the subjects experienced flu shot reaction described as injection site redness, swelling injection site and injection site pain. The office reported that they have administered approximately 50 FLULAVAL vaccinations and about 10 of these subjects have experienced reactions to the flu shot. These reactions have ranged from minor redness at injection site to large area of redness, swelling and pain at injection site. Some of the subject required treatment with ice and prednisone. At the time of the report individual subjects could not be identified. At the time of reporting the outcome of the injection site redness, swelling injection site and injection site pain were unspecified. Follow-up information was received on 26 October 2012 via physician. The physician reported that "out of about 300 vaccinations this year with FLULAVAL he has seen a large number of adverse events, roughly 10 to 12". He described them as "one diffuse rash and the other rashes local to injection site. These local reaction range from golf ball sized hard red reactions to involving the whole extremity. He screened these patients for previous adverse events." At the time of the report the outcome of the events were unspecified.
This spontaneous report received from a medical assistant referred to unspecified patients of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. Medical assistant reported that on unspecified dates, multiple, unspecified patients received improperly stored doses of GARDASIL 9 (lot: M009378 expiry: 23-APR-2018 and lot: M024261; expiry: 30-JUL-2018). No adverse effects reported. There had been three temperature excursions for GARDASIL 9 (lot: M009378; expiry: 23-APR-2018) 35F for 6 days, 35F for 5 minutes and 35F for 5 minutes. There had been two temperature excursions for GARDASIL 9 (lot: M024261; expiry: 30-JUL-2018) 35F for 5 minutes and 35F for 5 minutes. Additional information has been requested. Sender's Comments: US-009507513-1612USA007769: same reporter.
Lt sided weakness, subjective fevers, body aches, seen in the ER, continues to have symptoms
Terrible headache, neck and shoulder aching, high temperatures, profuse sweating, body aches, chills.  March 16th to Marche 21.
I woke up at 02:00AM, I woke up shaking violently with chills and with a 102.2 fever. I took an acetaminophen and drank ice water and got under the covers so I wasn't shaking anymore, I slept fitfully alternating between being cold and feverish. I got up about 7:30 with a terrible headache and feeling achy my temperature had risen to 102.3. I took more acetaminophen during the day and drank ice water. I took my temperature and it was 101. The rest of the day I felt weak, then at dinner time my headache started to regulate.
Received flu vaccine on 10/2/12. 10/3/12 Reported to nurses station c/o Rt. arm tender. Bony tenderness over acromium, large 1/2 dollar sized erythema circular area at injection site. Sent to ER for eval. No further tx.
Patient is a 26 y.o. male who received the Janssen Covid-19 Vaccine, Ad26.COV2.S (PF) 0.5 mL IM Susp, Lot 1805020 on 3/12/2021.  Vaccine administered at 1610 and reaction was immediate. The patient experienced the following reaction(s) during the immediate observation:  pt presented chills and shivering upon administration of vaccination. Brief altered mental status and decrease in HR. Staff talked pt through symptoms.  PT stated "I pass out after hang a shot." Also informed staff that he is a runner. 1621 VS- 100/62, P-56, R-99, noted pale, shivers, clammy hands and cold 1627 VS P-61, O2-100% 1629- BP 104/64 and shivers improving 1635- Stood patient up and moved him to chair in post vaccination area  1637 VS 102/64, P-61, O2 sat- 100%, R-22 1652- P-50, O2-99% 1659- P-47-56, O2 sat 100%, BP- 122/62- good color, shivers resolved   HR Increased to 56. Pt is now stable and ambulating. Patient was treated/managed as follows:  assessed vitals until wnl, wrapped patient and covered, cool damp cloth, offered therapeutic communication, cool water, and stayed with patient until he was able to ambulate. Left vaccination site accompanied by mother @ 1720.   Patient given educational material regarding vaccine and advised to continue to self-monitor per the agency guidance. Education patient on how to seek primary provider or additional medical management if symptoms return.
EE c/o headache, fever, and arm swelling and redness starting on 9/18/07 - day after Tdap on same arm where Tdap given. She self treated with warm/cold compresses. Advil for HA, fever with positive results. She's better today.
NauseaVomiting, HYPERtension & HYPERglycemia Narrative:
This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (vision is detreated) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 023M20A) for COVID-19 vaccination.  The patient's past medical history included Cataract operation (First cataract Surgery) on 22-Jun-2021.Previously administered products included for Product used for unknown indication: Prolia. Concomitant products included CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM + VIT D), MATURE MULTIVITAMINS and LUTEIN [XANTOFYL] from 15-Mar-2021 to an unknown date for an unknown indication.On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced VISUAL IMPAIRMENT (vision is detreated). At the time of the report, VISUAL IMPAIRMENT (vision is detreated) had not resolved. Concomitant included Bio flex was noted.No treatment medications were provided.Most recent FOLLOW-UP information incorporated above includes:On 20-Jul-2021: Significant follow up received included outcome of event updated unknown to not recovered. Concomitant and surgical procedure were added.
sleepy; This is a spontaneous report from a Pfizer-sponsored program. A contactable other hcp reported for 58-year-old male patient (reporter son) received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, She reported that her son, an HCP, received his first dose of the Pfizer COVID-19 vaccine and he was sleepy. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Dizziness, Muscle weakness, Fever, Nasal discharge and associated cough, loss of appetite, redness at injection site.
patient developed tinnitus that evening and has been experiencing tinnitus ever since. No prior history of tinnitus.
Patient given vaccine. Patient reported he had not been given a Covid-19 vaccine in the past, when in  it shows he has had 2 Moderna Shots administered. 02/09/2021 and 3/09/2021. After Janssen vaccine administered. Patient was monitored and had no adverse reactions. Thank you
5hr p/vax pt c/o pain on lt arm @ site & under arm radiating down lt side;site had a lump, no redness or tenderness noted;advised to apply ice to site & call pvt MD;
OUT OF BODY FEELING; FEELS HIGH LIKE FROM MARIJUANA; DRY COUGH; BRUTAL HEADACHE; This spontaneous report received from a patient concerned a 30 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855194 expiry: 09-APR-2022) dose was not reported, administered on 15-DEC-2021 for prophylactic vaccination. No concomitant medications were reported.  On DEC-2021, the patient experienced dry cough, and brutal headache. On 15-DEC-2021, the patient experienced feels high like from marijuana. On 17-DEC-2021, the patient experienced out of body feeling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the feels high like from marijuana, brutal headache, dry cough and out of body feeling was not reported. This report was non-serious.
Hives starting on lower left leg spreading to above the knee.  Treated with topical benadryl.
Right arm covid bivalent shot - immediately after administration I was bleeding all the way down to my arm. Within the following 24 hours the injection site swelled up to form a muscular knot and is significantly bruised. I never get bruised from shots, and the left arm injection site for the Flu shot has zero of these symptoms. I do not bruise easily, whereas my mother does and even she did not bruise from this shot.
Information has been received from a physician concerning a female patient (demographics not provided) who on an unspecified date was vaccinated with the first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast) (Lot# not provided). Subsequently the patient developed a rash on her face and stomach. The patient sought unspecified medical advice. Additional information has been requested.
Patient developed redness and swelling at the injection site, complained of running a fever over the weekend 100.2 F after advil and body aches. Today Temp 97.2 F, 4" diameter of redness and 1" diameter of induration at injection site. Seen in our Occupational Medicaine department and pallitive care instructions given.
Pfizer vaccine was diluted with NS 0.9% Bacteriostatic which is not recommended for use with this vaccines. Reported to Pfizer and CDC. As per recommendation from CDC, affected dose should be repeated. Pt was notified and all questions answered. Pt repeated dose on 9/15/21.
anaphylactic reaction; This is a spontaneous report from a contactable physician via a sales representative. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced an anaphylactic reaction 8 hours after receiving the Covid-19 vaccine. The outcome of the event was unknown.  Information about Batch/Lot number has been requested.; Sender's Comments: Based on the compatible temporal association and the drug's known safety profile, the Company considers the anaphylactic reaction is possibly related to BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) vaccination. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Employee experienced swelling and redness of upper extremities about one hour after flu shot administration. epinephrine 1:1000subq .5mg given and was transported to the doctor's office.
Pt recvd vax 10 days p/vax; No further details were provided; MD reported 15 similar pts;
Intussusception  5/15/07 Received vax records from reporter.  Lot numbers corrected in VAERS database.  RO lot number & dose confirmed by vax records.  5/25/07 Received medical records from hospital which reveal patient experienced emesis, bloody stools, abdominal pain & lethargy.  IS at right hepatic flexure diagnosed by abd US & reduced by barium enema.  Admitted 4/27 & d/c later same day after observation s/p IS reduction. Consult by peds surgery done. FINAL DX: Intussusception.
she tested positive for Covid-19; she tested positive for Covid-19; This is a spontaneous report from a non-contactable nurse (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration on 28Dec2020 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient said she received the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine last 28Dec2020, but on 04Jan2021, she tested positive for Covid-19. She said she has been quarantined since and was asymptomatic. Patient said she was due to receive the 2nd dose on the 18th of January and wants to know if that was okay. Outcome of the event was unknown.  No follow up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: The patient received the single dose of BNT162B2 on 28Dec2020, and was diagnosed with COVID-19 on 04JAN2021.  No effect of the suspect vaccine could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag. The company considers that the COVID-19 infection is more pre-existing infection prior to vaccine use, and unrelated to BNT162B2.
Extremely sore shoulder and arm, even to barely touch. Very sore underarm area, next to her breast tissue. Feeling weak and chilly without noticable fever. Discomfort started gradually and then quickly continued to worsen. Difficulty sleeping due to amount of discomfort.
Patient presented to clinic 2 days after receiving the flu/pneumonia vaccines with the following complaint: Brief Assessment of Chief Complaint: Pt reports elevated blood pressure at home this am. Pt took his atenolol and Lisinopril at 1145 this am. BP 136/105 in triage and 180/80 at 1445. Pt also has redness and swelling of left upper arm. Pt states he had a pneumonia vaccine on 10/12/17 and started to swell and itch shortly after administration.
Extreme pain, swelling, unable to move right arm for 24 hours.  Took Tylenol, aspirin and Soma at different intervals, drank liquids and applied heating pad.  The next 16 hours pain lessened, able to move arm slightly.  Massaged injection sites and moved right arm by lifting right hand with my left hand.  By today 8/14/09 at 10 AM, I can move right arm, still have some pain on movement, and moderate soreness of right deltoid and muscles.  Pain has diminished and movement has improved.
10 days after child received MMR, child became irritable, loss of appetite and low grade temp with erythematous macular eruptions generalized.
Injection was at 12:00 Pm on 12/29/2020. At 12:20 PM i started to feel faint, slightly nauseous . I layed down on my office floor, , my heart rate went up to 140 BPM and BP was around 140/76. My MA checked it . One of my physician colleague's that was nearby checked on me as well as the nurse that gave me the injections. it took about 30-40 minutes for the symptoms to subside. I was sent to our Urgent care dept in the same clinic by wheelchair at around 12:30-12:40 pm. I was evaluated and my symptoms subsided in 30-40 minutes. I was out of Urgent care at 1:25 pm, able to walk upstairs back to my office and felt okay and was seeing patients again at 1:30 PM.  This reaction was similar to getting a shot of Novocaine w/ epinephrine for a dental procedure I received a few years ago, so if I were to sum it up it was like getting a shot of epinephrine. it was not a vasovagal reaction as my BP was high. I have felt fine since. I plan to get the second vaccine. Any suggestions to avoid these symptoms w/ the second one would be appreciated.
21sep88 pt vax hepta B.  Following day pt devel. nausea/fever.  24oct88 pt vax 2nd hepta B.  Same day pt devel. nausea/fever, stiff neck, and pain in arm.  pt advised not to take 3rd dose.
become sick; very bad infection on left side of jaw; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (become sick) and INFECTION (very bad infection on left side of jaw) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (become sick) and INFECTION (very bad infection on left side of jaw). At the time of the report, ILLNESS (become sick) and INFECTION (very bad infection on left side of jaw) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Contact with and (suspected) exposure to other viral communicable diseases - issues with her O2 saturations and shortness of breath & COUGH   Registered Nurse  Progress Notes     Signed Encounter Date:  10/21/2021      Signed       Hide copied text  Hover for details  Verified the following for the patient prior to giving injections:   Code status:Full Code Allergies: No known drug allergies Weight: 174 Positive test date: 10/18/21   Symptoms patient is experiencing today are:   Administered casirivimab 600mg along with imdevimab 600mg as 4 subcutaneous injections of 2.5ml each.   Lot #: 8408100007 Exp. Date: 05/31/2023   Time injections administered:1650   Injection sites: 2.5ml subcutaneous -  Left upper arm,back 2.5mg subcutaneous - Right upper arm,back 2.5mg subcutaneous -  Left outer thigh 2.5mg subcutaneous - Right outer thigh   Patients response to injections: Tolerated well   Patient was re-evaluated at: 1750   Vitals signs at re-evaluation are: stable   Injection sites at re-evaluation are: (description) No redness, swelling, or bruising Report given to charge nurse prior to leaving the facility.
Red, swollen, warm measuring 4" x 4 1/2" in the left thigh.
The pt experienced a rash that started on the legs like red pimples then spread to the arms. The "little red dots" are slightly raised and then spread to the trunk and back.
BLACK SPOTS; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. On 2023, the patient experienced black spots. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of black spots was not reported. This report was non-serious.
Swollen left arm, deep headache, chest discomfort, body aches, joint stiffness, skin flushness, 101 fever, nausea, and brain fog. Symptoms lasted 4 days with Tylenol and vitamins as treatment. Doctor was not notified at the time. I will follow up with PCP on 12/6/21.
Patient presented to clinic with a dime size pustule with clear drainage, surrounded by and streaking redness, and warm to touch.
This spontaneous report as received from a physician who reported that 90-100 patients were inadvertently administered 5 vaccines for prophylaxis from December 2013 to March 2014 that had been improperly stored. This report refers to unknown number of these patients who were vaccinated with VARIVAX that had been improperly stored. No adverse effects reported. This is one of several reports received from the same source. Additional information is not expected.
On 12 April, her Platelets was dropped to 66x10(3)/ul  Vs  142 before (Mar 04, 2020). Continuously, it dropped to low as  18X10(3)/ul. She is on continues treatment, with  pantoprazole 40 mg and Rituximab-ABBS (TRUXIMA)  infusion
Initially employee experienced flushing, palpatations, nausea. ER- developed hives on arms TX:Prednison 60mg po given at 11:53am        Benadryl 50mg po given at 11:52am Observed for 2 hours with symptom resolution.  Discharged with oral steroids.